Practical considerations for Collaborative Research between the pharmaceutical industry and external investigators
Maureen Lloyd,1 Cynthia K Barbitsch,2 Mary Voehl Hirsch,3 Antonia Panayi,4 Eric Southam5
News and events
Spotlight news
March 16, 2026
Our 2024/2025 ESG report marks a year of progress
We are pleased to announce the release of our ESG report for 2024/2025, which describes our collective progress across environmental sustainability, social responsibility and ethical governance.
All
- All
- News
- Articles
- Events
Oxford PharmaGenesis Arrives in Cambridge
Continued growth has led Oxford PharmaGenesis, the leading HealthScience communications consultancy, to create a new UK office in Cambridge.
Oxford PharmaGenesis at World Orphan Drug Congress 2019
In mid-November Barcelona played host to the World Orphan Drug Congress 2019, Europe’s largest commercially focused conference for the rare disease community. Representatives from Oxford PharmaGenesis were in attendance over the 3-day meeting. The conference was broad-ranging in terms of sessions and speakers; however, there were some sessions of particular note.
Project Management Society's Patient Engagement Interest Group 2019: Patient Collaboration Uncut
Empowerment, not tokenism. Earlier this month, members of the Oxford PharmaGenesis Patient Engagement Team attended the annual educational event hosted by the Project Management Society in London. The event was held at the British Academy on the Mall, and featured several speakers and an expert panel selected to explore what it means to co-create with…
Oxford PharmaGenesis Inc. celebrates its third consecutive year as a Great Place to Work®
Oxford PharmaGenesis Inc. has been named as a Great Place to Work® for the third consecutive year!
Open Pharma and Oxford PharmaGenesis at the latest MedComms Brunch Club
At the October meeting of the MedComms Brunch Club in Oxford, employees of Oxford PharmaGenesis used this year’s Open Access Week as an opportunity to launch the Open Pharma position statement on open access and to present Oxford PharmaGenesis-funded research on open access, clinical trial transparency and the role of professional medical writing support.
